166 related articles for article (PubMed ID: 11028836)
1. The use of 5-HT3 receptor antagonists in various rheumatic diseases--a clue to the mechanism of action of these agents in fibromyalgia?
Stratz T; Müller W
Scand J Rheumatol Suppl; 2000; 113():66-71. PubMed ID: 11028836
[TBL] [Abstract][Full Text] [Related]
2. [5-HT3-receptor-antagonists in therapy of rheumatic diseases].
Müller W; Stratz T
Z Rheumatol; 2003 Feb; 62(1):39-41. PubMed ID: 12624802
[No Abstract] [Full Text] [Related]
3. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
[TBL] [Abstract][Full Text] [Related]
4. Do predictors exist for the therapeutic effect of 5-HT3 receptor antagonists in fibromyalgia?
Stratz T; Müller W
Scand J Rheumatol Suppl; 2000; 113():63-5. PubMed ID: 11028835
[TBL] [Abstract][Full Text] [Related]
5. [5-HT3 receptor antagonist als analgetics in rheumatic diseases].
Müller W; Fiebich BL; Stratz T
Z Rheumatol; 2006 Oct; 65(6):546, 548-52. PubMed ID: 16450149
[TBL] [Abstract][Full Text] [Related]
6. Current experience with 5-HT3 receptor antagonists in fibromyalgia.
Späth M
Rheum Dis Clin North Am; 2002 May; 28(2):319-28. PubMed ID: 12122920
[TBL] [Abstract][Full Text] [Related]
7. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.
Papadopoulos IA; Georgiou PE; Katsimbri PP; Drosos AA
Clin Rheumatol; 2000; 19(1):6-8. PubMed ID: 10752491
[TBL] [Abstract][Full Text] [Related]
8. [5-HT3 receptor antagonists as a new therapeutic principle in rheumatology?].
Pongratz D
Z Rheumatol; 2001 Feb; 60(1):47-8. PubMed ID: 11263014
[No Abstract] [Full Text] [Related]
9. Results of the intravenous administration of tropisetron in fibromyalgia patients.
Müller W; Stratz T
Scand J Rheumatol Suppl; 2000; 113():59-62. PubMed ID: 11028834
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects of 5-HT3 receptor antagonists.
Riering K; Rewerts C; Zieglgänsberger W
Scand J Rheumatol Suppl; 2004; 119():19-23. PubMed ID: 15515407
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors].
Stratz T; Schochat T; Hrycaj P; Lacki J; Mennet P; Färber L; Schweiger C; Müller W
Z Rheumatol; 1994; 53(6):335-8. PubMed ID: 7871905
[TBL] [Abstract][Full Text] [Related]
12. Effect of tropisetron on circulating catecholamines and other putative biochemical markers in serum of patients with fibromyalgia.
Höcherl K; Färber L; Ladenburger S; Vosshage D; Stratz T; Müller W; Grobecker H
Scand J Rheumatol Suppl; 2000; 113():46-8. PubMed ID: 11028831
[TBL] [Abstract][Full Text] [Related]
13. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions--preliminary clinical experience.
Hrycaj P
Scand J Rheumatol Suppl; 2004; 119():55-8. PubMed ID: 15515416
[TBL] [Abstract][Full Text] [Related]
14. New treatment options using 5-HT3 receptor antagonists in rheumatic diseases.
Müller W; Fiebich BL; Stratz T
Curr Top Med Chem; 2006; 6(18):2035-42. PubMed ID: 17017973
[TBL] [Abstract][Full Text] [Related]
15. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
[TBL] [Abstract][Full Text] [Related]
16. The influence of the 5-HT3 receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study.
Koeppe C; Schneider C; Thieme K; Mense S; Stratz T; Müller W; Flor H
Scand J Rheumatol Suppl; 2004; 119():24-7. PubMed ID: 15515408
[TBL] [Abstract][Full Text] [Related]
17. [Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron].
Stratz T; Müller W
Schmerz; 2003 Jun; 17(3):200-3. PubMed ID: 12789487
[TBL] [Abstract][Full Text] [Related]
18. [Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias].
Stratz T; Müller W
Fortschr Med Orig; 2002; 120(1):17-20. PubMed ID: 14518353
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone.
Samborski W; Stratz T; Mackiewicz S; Müller W
Scand J Rheumatol Suppl; 2004; 119():51-4. PubMed ID: 15515415
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
Haus U; Varga B; Stratz T; Späth M; Müller W
Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
